Загрузка...
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2018-05-01
|
| Серии: | Experimental Hematology & Oncology |
| Предметы: | |
| Online-ссылка: | http://link.springer.com/article/10.1186/s40164-018-0104-y |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|